Exascale Labs Holdings Statistics
Total Valuation
XLAB has a market cap or net worth of $89.38 million. The enterprise value is $86.68 million.
| Market Cap | 89.38M |
| Enterprise Value | 86.68M |
Important Dates
The last earnings date was Monday, September 28, 2026, after market close.
| Earnings Date | Sep 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XLAB has 91.20 million shares outstanding.
| Current Share Class | 60.46M |
| Shares Outstanding | 91.20M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.04% |
| Float | 60.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.91 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.20
| Current Ratio | 0.20 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -42.71% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 19.08% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $1.48M |
| Profits Per Employee | -$1.22M |
| Employee Count | 10 |
| Asset Turnover | 2.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -90.11% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 8.60 |
| Relative Strength Index (RSI) | 16.82 |
| Average Volume (20 Days) | 80,281 |
Short Selling Information
The latest short interest is 73,108, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 73,108 |
| Short Previous Month | 518,598 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.12% |
| Short Ratio (days to cover) | 0.12 |
Income Statement
In the last 12 months, XLAB had revenue of $14.82 million and -$12.16 million in losses.
| Revenue | 14.82M |
| Gross Profit | 2.42M |
| Operating Income | -4.80M |
| Pretax Income | -12.16M |
| Net Income | -12.16M |
| EBITDA | -4.79M |
| EBIT | -4.80M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $2.69 million in cash and no debt, with a net cash position of $2.69 million or $0.03 per share.
| Cash & Cash Equivalents | 2.69M |
| Total Debt | n/a |
| Net Cash | 2.69M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | -25.16M |
| Book Value Per Share | n/a |
| Working Capital | -25.36M |
Cash Flow
| Operating Cash Flow | -4.01M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6,925 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.01M |
| FCF Per Share | -$0.04 |
Margins
Gross margin is 16.31%, with operating and profit margins of -32.39% and -82.05%.
| Gross Margin | 16.31% |
| Operating Margin | -32.39% |
| Pretax Margin | -82.05% |
| Profit Margin | -82.05% |
| EBITDA Margin | -32.34% |
| EBIT Margin | -32.39% |
| FCF Margin | n/a |
Dividends & Yields
XLAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.89% |
| FCF Yield | -4.58% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XLAB has an Altman Z-Score of -4.36 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.36 |
| Piotroski F-Score | 3 |